01204nas a2200421   4500000000100000000000100001000000100002008004100003653001500044653000900059653003400068653004300102653002100145653001100166653000900177653004000186653002600226653001700252653003900269653003200308653001500340653002700355653004500382653002700427100001400454700001800468700001300486700001700499700001300516700001500529700001400544700001300558245016300571250001500734300001200749490000700761020001400768       2022                            d10aAdolescent10aAged10a*Brain Ischemia/complications10a*Cardiovascular Diseases/complications10aCholesterol, LDL10aHumans10aMale10a*Myocardial Infarction/drug therapy10aRetrospective Studies10aRisk Factors10a*Stroke/complications/epidemiology10aUnited Kingdom/epidemiology10aCardiology10aCoronary heart disease10aGENERAL MEDICINE (see Internal Medicine)10aQuality in health care1 aM. Danese1 aE. Sidelnikov1 aG. Villa1 aD. Catterick1 aM. Iqbal1 aM. Gleeson1 aD. Lubeck1 aJ. Patel00aLongitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK  a2022/04/30  ae0550150 v12  a2044-6055